The classical drug discovery paradigm begins with a known molecular target: a protein whose modulation is expected to reverse ...

For the first time, scientists have succeeded in artificially mimicking the ion signaling of heart muscle cells. To succeed, researchers at LiU have used organic electronics based on conductive ...

Researchers identified key differences between two widely used multiple sclerosis models, showing how each can better study myelin damage, immune responses, and repair. The findings may improve ...

Scientists at the Icahn School of Medicine at Mount Sinai have created a new artificial intelligence (AI) model that helps reveal how genes function together inside human cells, offering a powerful ...

Bristol Myers Squibb is mispriced as a melting ice cube, despite its Growth Portfolio surpassing Legacy revenues in Q1 2026.

Northwestern researchers have shown that when it comes to cancer vaccines, arrangement can be just as important as ingredients. By repositioning a small fragment of an HPV protein on a DNA-based ...

Aplagon, a clinical-stage biotech developing first-in-class therapies for thromboinflammatory diseases, today announced the comprehensive publication of an invited review article in Arteriosclerosis, ...

By David Bautz, PhD NASDAQ: FBLG Business Update Phase 1/2 Trial of CYWC628 Underway On June 3, 2026, FibroBiologics, Inc.

Researchers in the lab of Cancer Center at Illinois (CCIL) member Xing Wang have discovered the influential role of ...

It's tricky to make an exact copy of yourself. Or at least it is for cells undergoing mitosis, where cells replicate everything inside of them, including their neatly packaged DNA, then split in half.